Boston Heart Diagnostics Corporation
NPI 1922259753 · Clinical Medical Laboratory · Framingham, MA
Enrolled with Medicare as Part B Supplier - Independent Clinical Laboratory · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Boston Heart Diagnostics Corporation is a Clinical Medical Laboratory organization in Framingham, MA (NPI 1922259753).
Provider details
- NPI number
- 1922259753
- Entity type
- Organization
- Primary specialty
- Clinical Medical LaboratoryLaboratories
- Organization subpart
- No
- Authorized official
- Matthew Urbanek, Director(816) 799-1610
Specialties & taxonomies
Laboratories
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure28% of score
17 yrs in NPPES registry
- Profile completeness28% of score
100% of core fields populated
- Practice footprint17% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)28% of score
531,883 Medicare services, 2024 (ranked within specialty)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our methodology.
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Apolipoprotein Level82172 | 34,589 | $21 |
| Organic Acid Level83921 | 29,023 | $21 |
| Measurement C-Reactive Protein for Detection of Infection Or Inflammation, High Sensitivity86141 | 21,170 | $13 |
| Blood Test, Lipids (cholesterol and Triglycerides)80061 | 20,639 | $13 |
| Measurement of Substance Using Immunoassay Technique, By Radioimmunoassay83519 | 18,808 | $18 |
| Lipoprotein (a) Level83695 | 18,789 | $14 |
| Insulin Measurement, Total |
Practice location
Mailing address
Other names (DBA / former)
- Former legal business name
- Boston Heart Lab Corporation
- Former legal business name
- Boston Heart Lab Corporation
Registry dates
- Enumerated
- 2008-10-10
- Last updated
- 2025-11-18
- Certified
- 2025-11-18
Frequently asked questions
- What is Boston Heart Diagnostics Corporation's NPI number?
- Boston Heart Diagnostics Corporation's National Provider Identifier (NPI) is 1922259753, a unique 10-digit ID issued by CMS for use in standard healthcare transactions.
- What type of organization is Boston Heart Diagnostics Corporation?
- Boston Heart Diagnostics Corporation is classified in the NPPES registry as Clinical Medical Laboratory (Laboratories).
- Where is Boston Heart Diagnostics Corporation located?
- Boston Heart Diagnostics Corporation's practice location on file with NPPES is 200 Crossing Blvd Ste 200, Framingham, MA 01702-4486.
- What is Boston Heart Diagnostics Corporation's phone number?
- The practice phone number listed in the NPPES registry for Boston Heart Diagnostics Corporation is (508) 877-8711.
- Does Boston Heart Diagnostics Corporation accept Medicare?
- Boston Heart Diagnostics Corporation is approved to bill Medicare according to CMS PECOS enrollment data (2026.04.01). Confirm current participation with the provider before scheduling.
- Who is the authorized official for Boston Heart Diagnostics Corporation?
- The authorized official listed on Boston Heart Diagnostics Corporation's NPPES record is Matthew Urbanek, Director. The authorized official registers and maintains the organization's NPI and is not necessarily its owner.
- Is Boston Heart Diagnostics Corporation's NPI active?
- Yes — Boston Heart Diagnostics Corporation's NPI (1922259753) is active in the NPPES registry as of the last update on 2025-11-18.
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.